Limits...
Is the smokers exposure to environmental tobacco smoke negligible?

Piccardo MT, Stella A, Valerio F - Environ Health (2010)

Bottom Line: In a controlled situation of indoor active smoking, we compared daily benzo(a)pyrene (BaP) dose, estimated to be inhaled by smokers due to the mainstream (MS) of cigarettes they have smoked, to the measured environmental tobacco smoke (ETS) they inhaled in an indoor environment.In smoker subjects, the percentage of BaP daily dose due to ETS, in comparison to mainstream dose due to smoked cigarettes, was estimated with 95% confidence interval, between 14.6% and 23% for full flavour cigarettes and between 21% and 34% for full flavour light cigarettes.During indoor smoking, ETS contribution to total BaP dose of the same smoker, may be not negligible.

View Article: PubMed Central - HTML - PubMed

Affiliation: Environmental Chemistry Laboratory, National cancer Research Institute, Genoa Lgo Rosanna Benzi n 10, 16132 Genoa, Italy. mariateresa.piccardo@istge.it

ABSTRACT

Background: Very few studies have evaluated the adverse effect of passive smoking exposure among active smokers, probably due to the unproven assumption that the dose of toxic compounds that a smoker inhales by passive smoke is negligible compared to the dose inhaled by active smoke.

Methods: In a controlled situation of indoor active smoking, we compared daily benzo(a)pyrene (BaP) dose, estimated to be inhaled by smokers due to the mainstream (MS) of cigarettes they have smoked, to the measured environmental tobacco smoke (ETS) they inhaled in an indoor environment. For this aim, we re-examined our previous study on daily personal exposure to BaP of thirty newsagents, according to their smoking habits.

Results: Daily BaP dose due to indoor environmental contamination measured inside newsstands (traffic emission and ETS produced by smoker newsagents) was linearly correlated (p = 0.001 R2 = 0.62) with estimated BaP dose from MS of daily smoked cigarettes. In smoker subjects, the percentage of BaP daily dose due to ETS, in comparison to mainstream dose due to smoked cigarettes, was estimated with 95% confidence interval, between 14.6% and 23% for full flavour cigarettes and between 21% and 34% for full flavour light cigarettes.

Conclusions: During indoor smoking, ETS contribution to total BaP dose of the same smoker, may be not negligible. Therefore both active and passive smoking exposures should be considered in studies about health of active smokers.

Show MeSH

Related in: MedlinePlus

BaP daily dose from environmental sources versus BaP dose from mainstream of daily smoked cigarettes. Figure shows linear correlation between daily dose of Env-BaP and MS-BaP dose of 15 non-smoking and 15 smoking newsagents, in Genoa, during 1998. MS-BaP dose was estimated from mean BaP content in FFL cigarettes mainstream [1]. Dotted curves define 95% confidence limits, according uncertainty of measured BaP air concentrations and variability of BaP quantity estimated in mainstream of FFL cigarettes sold in U.S. and Italian market, from 1995 and 2000.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC2823725&req=5

Figure 1: BaP daily dose from environmental sources versus BaP dose from mainstream of daily smoked cigarettes. Figure shows linear correlation between daily dose of Env-BaP and MS-BaP dose of 15 non-smoking and 15 smoking newsagents, in Genoa, during 1998. MS-BaP dose was estimated from mean BaP content in FFL cigarettes mainstream [1]. Dotted curves define 95% confidence limits, according uncertainty of measured BaP air concentrations and variability of BaP quantity estimated in mainstream of FFL cigarettes sold in U.S. and Italian market, from 1995 and 2000.

Mentions: Figure 1 shows the correlation between measured Env-BaP and estimated MS-BaP doses, supposing all smoked cigarettes of FFL category. The weighted least squares regression line and its 95% confidence limits (dotted curves) are shown in the figure. Env-BaP and MS-BaP doses are linearly correlated.


Is the smokers exposure to environmental tobacco smoke negligible?

Piccardo MT, Stella A, Valerio F - Environ Health (2010)

BaP daily dose from environmental sources versus BaP dose from mainstream of daily smoked cigarettes. Figure shows linear correlation between daily dose of Env-BaP and MS-BaP dose of 15 non-smoking and 15 smoking newsagents, in Genoa, during 1998. MS-BaP dose was estimated from mean BaP content in FFL cigarettes mainstream [1]. Dotted curves define 95% confidence limits, according uncertainty of measured BaP air concentrations and variability of BaP quantity estimated in mainstream of FFL cigarettes sold in U.S. and Italian market, from 1995 and 2000.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC2823725&req=5

Figure 1: BaP daily dose from environmental sources versus BaP dose from mainstream of daily smoked cigarettes. Figure shows linear correlation between daily dose of Env-BaP and MS-BaP dose of 15 non-smoking and 15 smoking newsagents, in Genoa, during 1998. MS-BaP dose was estimated from mean BaP content in FFL cigarettes mainstream [1]. Dotted curves define 95% confidence limits, according uncertainty of measured BaP air concentrations and variability of BaP quantity estimated in mainstream of FFL cigarettes sold in U.S. and Italian market, from 1995 and 2000.
Mentions: Figure 1 shows the correlation between measured Env-BaP and estimated MS-BaP doses, supposing all smoked cigarettes of FFL category. The weighted least squares regression line and its 95% confidence limits (dotted curves) are shown in the figure. Env-BaP and MS-BaP doses are linearly correlated.

Bottom Line: In a controlled situation of indoor active smoking, we compared daily benzo(a)pyrene (BaP) dose, estimated to be inhaled by smokers due to the mainstream (MS) of cigarettes they have smoked, to the measured environmental tobacco smoke (ETS) they inhaled in an indoor environment.In smoker subjects, the percentage of BaP daily dose due to ETS, in comparison to mainstream dose due to smoked cigarettes, was estimated with 95% confidence interval, between 14.6% and 23% for full flavour cigarettes and between 21% and 34% for full flavour light cigarettes.During indoor smoking, ETS contribution to total BaP dose of the same smoker, may be not negligible.

View Article: PubMed Central - HTML - PubMed

Affiliation: Environmental Chemistry Laboratory, National cancer Research Institute, Genoa Lgo Rosanna Benzi n 10, 16132 Genoa, Italy. mariateresa.piccardo@istge.it

ABSTRACT

Background: Very few studies have evaluated the adverse effect of passive smoking exposure among active smokers, probably due to the unproven assumption that the dose of toxic compounds that a smoker inhales by passive smoke is negligible compared to the dose inhaled by active smoke.

Methods: In a controlled situation of indoor active smoking, we compared daily benzo(a)pyrene (BaP) dose, estimated to be inhaled by smokers due to the mainstream (MS) of cigarettes they have smoked, to the measured environmental tobacco smoke (ETS) they inhaled in an indoor environment. For this aim, we re-examined our previous study on daily personal exposure to BaP of thirty newsagents, according to their smoking habits.

Results: Daily BaP dose due to indoor environmental contamination measured inside newsstands (traffic emission and ETS produced by smoker newsagents) was linearly correlated (p = 0.001 R2 = 0.62) with estimated BaP dose from MS of daily smoked cigarettes. In smoker subjects, the percentage of BaP daily dose due to ETS, in comparison to mainstream dose due to smoked cigarettes, was estimated with 95% confidence interval, between 14.6% and 23% for full flavour cigarettes and between 21% and 34% for full flavour light cigarettes.

Conclusions: During indoor smoking, ETS contribution to total BaP dose of the same smoker, may be not negligible. Therefore both active and passive smoking exposures should be considered in studies about health of active smokers.

Show MeSH
Related in: MedlinePlus